Have a personal or library account? Click to login
Immunotherapy with Interleukin-2: A Study Based on Mathematical Modeling Cover

Immunotherapy with Interleukin-2: A Study Based on Mathematical Modeling

By: Sandip Banerjee  
Open Access
|Oct 2008

References

  1. Adam J. and N. Bellomo E. (1997). A Survey Models for Tumor-Immune System Dynamics, Birkhäuser, Boston, MA.10.1007/978-0-8176-8119-7
  2. Banerjee S. and Sarkar R. R. (2008). Delay induced model for tumor-immune interaction and control of malignant tumor growth, Biosciences91(1): 268-288.10.1016/j.biosystems.2007.10.002
  3. Bodnar M. and Foryś U. (2000a). Behaviour of solutions to Marchuk's model depending on a time delay, International Journal of Applied Mathematics and Computer Science10(1): 97-112.
  4. Bodnar M. and Foryś U. (2000b). Periodic dynamics in the model of immune system, International Journal of Applied Mathematics and Computer Science10(1): 113-126.10.4064/am-27-1-113-126
  5. Bodnar M. and Foryś U. (2003a). Time delays in proliferation process for solid avascular tumor, Mathematical and Computer Modeling37(11): 1201-1209.10.1016/S0895-7177(03)80019-5
  6. Bodnar M. and Foryś U. (2003b). Time delays in regulatory apoptosis for solid avascular tumor, Mathematical and Computer Modeling37(11): 1211-1220.10.1016/S0895-7177(03)00131-6
  7. Byrne H. M. (1997). The effect of time delays on the dynamics of avascular tumor growth, Mathematical Biosciences144(2): 83-117.10.1016/S0025-5564(97)00023-0
  8. Curti B. D., Ochoa A. C., Urba W. J., Alvord W. G., Kopp W. C., Powers G., Hawk C., Creekmore S. P., Gause B. L., Janik J. E., Holmlund J. T., Kremers P., Fenton R. G., Miller L., Sznol M., II J. W. S., Sharfman W. H. and Longo D. L. (1996). Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anticd3-stimulated t cells: Results from a phase i trial in cancer patients, Journal of Immunotherapy19(4): 296-308.10.1097/00002371-199607000-00005
  9. Foryś U. (2002). Marchuk's model of immune system dynamics with application to tumor growth, Journal of Theoretical Medicine4(1): 85-93.10.1080/10273660290052151
  10. Freedman H. I., Erbe L. and Rao V. S. H. (1986). Three species food chain models with mutual interference and time delays, Mathematical Biosciences80(1): 57-80.10.1016/0025-5564(86)90067-2
  11. Freedman H. I. and Rao V. S. H. (1983). The trade-off between mutual interference and time lags in predator-prey systems, Bulletin of Mathematical Biology45(6): 991-1004.10.1016/S0092-8240(83)80073-1
  12. Galach M. (2003). Dynamics of the tumor-immune system competition-the effect of time delay, International Journal of Applied Mathematics and Computer Science13(3): 395-406.
  13. Gause B. L., Sznol M., Kopp W. C., Janik J. E., II J. W. S., Steis R. G., Urba W. J., Sharfman W., Fenton R. G., Creekmore S. P., Holmlund J., Conlon K. C., VanderMolen L. A. and Longo D. L. (1996). Phase i study of subcutaneously administered interleuking-2 in combination with interferon alfa-2a in patients with advanced cancer, Journal of Clinical Oncology14(8): 2234-2241.10.1200/JCO.1996.14.8.2234
  14. Hale J. and Lunel S. (1993). Introduction to Functional Differential Equations, Springer-Verlag, New York, NY.10.1007/978-1-4612-4342-7
  15. Hara I., Hotta H., Sato N., Eto H., Arakawa S. and Kamidono S. (1996). Rejection of mouse renal cell carcinoma elicited by local secretion of interleukin-2, Japanese Journal of Cancer Research87(7): 724-729.10.1111/j.1349-7006.1996.tb00284.x
  16. Kaempfer R., Gerez L., Farbstein H., Madar L., Hirschman O., Nussinovich R. and Shapiro A. (1996). Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression, Journal of Clinical Oncology14(6): 1778-1786.10.1200/JCO.1996.14.6.1778
  17. Keilholz U., Scheibenbogen C., Stoelben E., Saeger H. D. and Hunstein W. (1994). Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: Pattern of progression in responders and patients with stable disease with or without resection of residual lesions, European Journal of Cancer30A(7): 955-958.10.1016/0959-8049(94)90122-8
  18. Kirschner D. and Panetta J. C. (1998). Modeling immunotherapy of the tumor — immune interaction, Journal of Mathematical Biology37(3): 235-252.10.1007/s002850050127
  19. Kolev M. (2003). Mathematical modeling of the competition between acquired immunity and cancer, International Journal of Applied Mathematics and Computer Science13(3): 289-296.
  20. Kuznetsov V. A., Makalkin I. A., Taylor M. A. and Perelson A. S. (1994). Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis, Bulletin of Mathematical Biology56(2): 295-321.10.1016/S0092-8240(05)80260-5
  21. Matzavinos A., A. J. Chaplain M. and Kuznetsov V. A. (2004). Mathematical modelling of the spatio-temporal response of cytotoxic t-lymphocytes to a solid tumor, Mathematical Medicine and Biology21(1): 1-34.10.1093/imammb/21.1.115065736
  22. Rabinowich H., Banks M., Reichert T. E., Logan T. F., Kirkwood J. M. and Whiteside T. L. (1996). Expression and activity of signaling molecules in t-lymphocytes obtained from patients with metastatic melanoma before and after interleukin-2 therapy, Clinical Cancer Research2(8): 1263-1274.
  23. Rosenberg S. A. and Lotze M. T. (1986). Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes, Annual Review of Immunology4(1): 681-709.10.1146/annurev.iy.04.040186.0033413518753
  24. Rosenberg S. A., Yang J. C., Topalian S. L., Schwartzentruber D. J., Weber J. S., Parkinson D. R., Seipp C. A., Einhorn J. H. and White D. E. (1994). Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2, Journal of the American Medical Association271(12): 907-913.10.1001/jama.271.12.907
  25. Rosenstein M., Ettinghousen S. E. and Rosenberg S. A. (1986). Extravasion of intravascular fluid mediated by the systemic administration of recombinant interleukin-2, Journal of Immunology137(5): 1735-1742.10.4049/jimmunol.137.5.1735
  26. Sarkar R. R. and Banerjee S. (2005). Cancer self remission and tumor stability — A stochastic approach, Mathematical Biosciences196(1): 65-81.10.1016/j.mbs.2005.04.001
  27. Schwartzentruber D. J. (1993). In vitro predictors of clinical response in patients receiving interleukin-2-based immunotherapy, Current Opinion in Oncology5(6): 1055-1058.10.1097/00001622-199311000-00018
  28. Szymańska Z. (2003). Analysis of immunotherapy models in the context of cancer dynamics, International Journal of Applied Mathematics and Computer Science13(3): 407-418.
  29. Tartour E., Blay J. Y., Dorval T., Escudier B., Mosseri V., Douillard J. Y., Deneux L., Gorin I., Negrier S., Mathio C., Pouillart P. and Fridman W. H. (1996). Predictors of clinical response to interleukin-2-based immunotherapy in melanoma patients: A French multi-institutional study, Journal of Clinical Oncology14(5): 1697-1703.10.1200/JCO.1996.14.5.1697
  30. Yang X., Chen L. and Chen J. (1996). Permanence and positive periodic solution for the single-species nonautonomous delay diffusive model, Computers and Mathematics with Applications32(4): 109-116.10.1016/0898-1221(96)00129-0
  31. Zhivkovc P. and Waniewski J. (2003). Modeling tumor-immunity interactions with different stimulation functions, International Journal of Applied Mathematics and Computer Science13(3): 307-315.
DOI: https://doi.org/10.2478/v10006-008-0035-6 | Journal eISSN: 2083-8492 | Journal ISSN: 1641-876X
Language: English
Page range: 389 - 398
Published on: Oct 6, 2008
Published by: University of Zielona Góra
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2008 Sandip Banerjee, published by University of Zielona Góra
This work is licensed under the Creative Commons License.

Volume 18 (2008): Issue 3 (September 2008)